Loading...
Theralase Technologies Inc.
TLTFF•PNK
Healthcare
Medical - Devices
$0.14
$-0.01(-9.03%)
Theralase Technologies Inc. (TLTFF) Financial Performance & Income Statement Overview
Review Theralase Technologies Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-3.45%
↓ 3.45%
Operating Income Growth
6.66%
↑ 6.66%
Net Income Growth
6.89%
↑ 6.89%
Operating Cash Flow Growth
18.33%
↑ 18.33%
Operating Margin
-474.43%
↓ 474.43%
Gross Margin
53.23%
↑ 53.23%
Net Profit Margin
-470.00%
↓ 470.004%
ROE
-256.58%
↓ 256.58%
ROIC
-358.17%
↓ 358.17%
Theralase Technologies Inc. (TLTFF) Income Statement & Financial Overview
Review Theralase Technologies Inc.'s (TLTFF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $410447.00 | $346583.00 | $100847.00 | $175554.00 |
| Cost of Revenue | $147269.00 | $145812.00 | $72884.00 | $175210.00 |
| Gross Profit | $263178.00 | $200771.00 | $27963.00 | $344.00 |
| Gross Profit Ratio | $0.64 | $0.58 | $0.28 | $0.002 |
| R&D Expenses | $652975.00 | $650612.00 | $693707.00 | $893094.00 |
| SG&A Expenses | $526798.00 | $499612.00 | $474245.00 | $568763.00 |
| Operating Expenses | $1.19M | $200771.00 | $27963.00 | $1.46M |
| Total Costs & Expenses | $1.34M | $346583.00 | $1.24M | $1.64M |
| Interest Income | $17870.00 | $17083.00 | $15157.00 | $16341.00 |
| Interest Expense | $5422.00 | $5834.00 | $6240.00 | $6639.00 |
| Depreciation & Amortization | $68583.00 | $68280.00 | $67185.00 | $68040.00 |
| EBITDA | -$844111.00 | -$863420.00 | -$1.06M | -$1.19M |
| EBITDA Ratio | -$2.06 | -$2.49 | -$10.51 | -$6.79 |
| Operating Income | -$925594.00 | $0.00 | -$1.14M | -$1.46M |
| Operating Income Ratio | -$2.26 | $0.00 | -$11.30 | -$8.33 |
| Other Income/Expenses (Net) | $7475.00 | -$937534.00 | $6240.00 | $6602.00 |
| Income Before Tax | -$918119.00 | -$937534.00 | -$1.13M | -$1.45M |
| Income Before Tax Ratio | -$2.24 | -$2.71 | -$11.24 | -$8.29 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$188200.00 |
| Net Income | -$918119.00 | -$937534.00 | -$1.13M | -$1.27M |
| Net Income Ratio | -$2.24 | -$2.71 | -$11.24 | -$7.22 |
| EPS | -$0.004 | -$0.004 | -$0.005 | -$0.005 |
| Diluted EPS | -$0.004 | -$0.004 | -$0.005 | -$0.005 |
| Weighted Avg Shares Outstanding | $247.78M | $234.62M | $231.89M | $229.47M |
| Weighted Avg Shares Outstanding (Diluted) | $247.78M | $234.62M | $231.89M | $229.47M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan